logo
Select company
Select metric
-5585.32%Operating Cash Flow Margin
VS
Market
2
Sector
8
Industry
15
History
13
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information

Ticker

LYRA

Company Name

LYRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYRA THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYRA - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -43.01M-5585.32%$ 770K
3/31/2025$ -56.4M-4759.32%$ 1.19M
12/31/2024$ -70.01M-4563.95%$ 1.53M
9/30/2024$ -77.72M-5283.28%$ 1.47M
6/30/2024$ -75.61M-4154.29%$ 1.82M
3/31/2024$ -69.91M-4161.25%$ 1.68M
12/31/2023$ -63.3M-4063.16%$ 1.56M
9/30/2023$ -56.41M-3964.16%$ 1.42M
6/30/2023$ -53.14M-4292.57%$ 1.24M
3/31/2023$ -47.33M-3626.82%$ 1.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, LYRA THERAPEUTICS INC's average OCF % has been -12887.04%.
  • The median OCF % for LYRA THERAPEUTICS INC during this period was -4157.77%
  • LYRA THERAPEUTICS INC reached its highest OCF % over the past 5 years at -533.17%.
  • The lowest OCF % recorded by LYRA THERAPEUTICS INC in the same timeframe -145650%

LYRA THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
APRE : APREA THERAPEUTICS INC -1514.98%BRTX : BIORESTORATIVE THERAPIES INC -1573.04%ERNA : ERNEXA THERAPEUTICS INC -2956.35%VYNE : VYNE THERAPEUTICS INC -8355.67%SXTP : 60 DEGREES PHARMACEUTICALS INC -748.71%LEXX : LEXARIA BIOSCIENCE CORP -1574.8%ICU : SEASTAR MEDICAL HOLDING CORP -2004.7%RLYB : RALLYBIO CORP -5517.87%IBIO : IBIO INC -3826%CODX : CO-DIAGNOSTICS INC -3237.53%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for LYRA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -21.14M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

LYRA - Operating Cash Flow Margin, Last 5 years

-145650%

Minimum

Sep 30, 2021

-533.17%

Maximum

Mar 31, 2022

-12887.04%

Average

-4157.77%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%